Furthermore, IS21 treatment with doxorubicin or vincristine treatment increased apoptosis in T-ALL human cell lines, especially in Jurkat cells, which, as mentioned above, have been shown to be the most resistant to single treatments with the inhibitor due to low levels of Bcl-2 [119]. Here, BCL2 is linked to acute lymphoblastic leukemia.